MSD Brazil


Brazil subsidiary of a global biopharmaceutical company focused on discovery, development, registration and commercialization of medicines and vaccines. Operates clinical trial programs (including global Phase 3 studies), medical information and pharmacovigilance channels, regulatory interactions with ANVISA, and public-health campaigns and real-world evidence generation in Brazil.

Industries

N/A


Products

Medicines and vaccines across multiple therapeutic areas

Commercialization and local regulatory maintenance of therapeutics and vaccines in oncology, infectious disease, vaccines, diabetes, anesthesia and rare diseases.


Services

Clinical trial conduct and management

Planning and operational delivery of multicenter clinical trials including site network coordination, patient recruitment, monitoring and data collection.

Medical information and pharmacovigilance services

Centralized channels for medical inquiries, adverse event reporting and product quality complaints, with case processing for regulatory reporting.

Regulatory submission and market‑access support

Preparation and submission of dossiers and notifications to national regulators, and coordination of product availability communications.

Public health campaign planning and execution

Design and implementation of awareness campaigns and educational activities to increase vaccination and screening uptake.

Expertise Areas

  • Clinical trial management (Phase 1–3)
  • Oncology drug development
  • Vaccine development and immunization programs
  • Pharmacovigilance and medical safety
  • Show More (4)

Key Technologies

  • Randomized double‑blind placebo‑controlled trial methodology
  • PD‑1 checkpoint inhibitor immunotherapy
  • Vaccine technologies (recombinant, conjugate, polysaccharide)
  • Antibody‑drug conjugates
  • Show More (5)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.